No Data
No Data
Junshi Bio (01877): Teriprizumab received a positive opinion from the Committee for Medicinal Products for Human Use of the European Medicines Agency.
Junshi Biosciences (01877) announced that the European commodity name for Teriprizumab monoclonal antibody is LOQTORZI...
Express News | Shanghai Junshi Biosciences - Receipt of Positive Opinion From Committee for Medicinal Products for Human Use of EMA for Toripalimab
The Market Doesn't Like What It Sees From Shanghai Junshi Biosciences Co., Ltd.'s (HKG:1877) Revenues Yet
Shanghai Junshi Biosciences' Supplementary NDA Accepted by Chinese Regulator
Junshi Biosciences Announces the Acceptance of the Supplemental New Drug Application for Toripalimab Combined With Bevacizumab for the First-Line Treatment of Advanced Hepatocellular Carcinoma
HKEX News | Junshi Biosciences (01877) rose more than 4% as the new application for Trelagliptin monoclonal antibody was accepted.
Junshi Bio (01877) rose more than 4%. As of press time, it rose 4.11% to HKD 13.16 with a turnover of HKD 4.2279 million.
No Data